Rail Study Report definition

Rail Study Report means a report setting out the outcomes of the Rail Study.
Sample 1Sample 2Sample 3

Examples of Rail Study Report in a sentence

  • If the Capacity Reviewer determines, during the period specified in clause 11.5(d), that the Capacity Model is incorrect, then Aurizon Network must, within 10 Business Days of the Capacity Reviewer’s determination, prepare and re-issue the Rail Study Report on the basis of the correct Capacity Model.

  • Aurizon Network may delete from the copy of the Rail Study Report which Aurizon Network is required to deliver to the Study Funder under clause 7.4(a) any information which, if disclosed to the Study Funder, would give rise to a breach of a contractual or other obligation (including an equitable obligation of confidence) by Aurizon Network.

  • If the Rail Study is a Feasibility Study, then on or before the date that is 5 Business Days after the Commencement Date, Aurizon Network must provide the Study Funder with a copy of the final Rail Study Report prepared by Aurizon Network for the Pre-feasibility Study for the Expansion.

  • The Rail Study Report delivered to the Study Funder under clause 7.4(a) must include the information required for the relevant Rail Study in the Access Undertaking.

  • Within 20 Business Days after Aurizon Network delivers the Rail Study Report to the Study Funder under clause 7.4, All Study Funders and Aurizon Network, may jointly appoint, all parties acting reasonably, a suitably skilled and experienced consultant approved by Aurizon Network (acting reasonably) (Capacity Reviewer) to review the Capacity Model (Capacity Review).

  • Summary The East-West Passenger Rail Study Report identified three potentially viable alternatives for passenger rail service between Western Massachusetts and Boston.

  • Within 20 Business Days after Aurizon Network delivers the Rail Study Report to the Study Funder under clause 7.4, All Study Funders and Aurizon Network, may jointly appoint, all parties acting reasonably, a suitabilitysuitably skilled and experienced consultant approved by Aurizon Network (acting reasonably) (Capacity Reviewer) to review the Capacity Model (Capacity Review).

  • It runs through Sonoma State University’s campus where it has become an asset to the community around it, however there are some issues within and around the creek that need to be met in order for the community’s full enjoyment of this valuable ecosystem.● Obstructive underbrush○ There are unnecessary bunches of underbrush along Copeland Creek that are both un­aesthetically pleasing and uninviting to the eye.

  • The most recent study of the Mountain Division as a railroad corridor is the report entitled “Mountain Division Rail Study: Report on Potential Uses and Implementation Costs”, authored by HNTB Corporation in 2007 for the MaineDOT Office of Freight Transportation.

  • Delaware-Maryland-Virginia Peninsula Rail Study; Report to CongressPub.

Related to Rail Study Report

  • Development Report means a written account of Licensee’s progress under the Development Plan having at least the information specified on Appendix B to this Agreement, and shall be sent to the address specified on Appendix B.

  • Progress Report means the report similar in form and content to that attached hereto as Appendix III.

  • Feasibility Report means a detailed written report of the results of a comprehensive study on the economic feasibility of placing the Property or a portion thereof into Commercial Production and shall include a reasonable assessment of the mineral ore reserves and their amenability to metallurgical treatment, a description of the work, equipment and supplies required to bring the Property or a portion thereof into Commercial Production and the estimated cost thereof, a description of the mining methods to be employed and a financial appraisal of the proposed operations supported by an explanation of the data used therein;

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Progress Reports The Progress Reports as required by the individual Task Work Orders issued pursuant to this Agreement. Responsible: Responsible or Responsibility means the financial ability, legal capacity, integrity and past performance of Contractor and as such terms have been interpreted relative to public procurements. See NYS Finance Law § 163(1)(c).

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Project Report means a summary statement of the likely environmental effects of a proposed development referred to in section 58;

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Pivotal Study means (a) a Phase 3 Study that is intended by Celgene to be submitted (together with any other registration trials that are prospectively planned when such Phase 3 Study is initiated) for Regulatory Approval in the U.S. or the EU, or (b) any other clinical study that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which clinical study is a registration trial intended to be sufficient for filing an application for a Regulatory Approval for the Licensed Product in the U.S. or another country or some or all of an extra-national territory, solely as evidenced by the acceptance for filing for a Regulatory Approval for such product after completion of such study.

  • Interconnection Feasibility Study means either a Generation Interconnection Feasibility Study or Transmission Interconnection Feasibility Study.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • MI Report means a report containing Management Information submitted to the Authority in accordance with Framework Schedule 8 (Management Information);

  • Feasibility Study means the evaluation and analysis of the potential of a project, which aims at supporting the process of decision-making by objectively and rationally uncovering its strengths and weaknesses, opportunities and threats, as well as identifying the resources required to carry it through and ultimately its prospects for success;

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Detailed Project Report or ‘‘DPR’’ means the detailed project report relating to Station Development Project and Redevelopment Project attached hereto;

  • Program of study means a curriculum that requires a candidate to demonstrate and document competency in the specific knowledge, skills, and dispositions for a particular endorsement to an educator’s license, a licensure content area, or level of licensure, and is:

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase I Report means, with respect to any Facility, a report that (i) conforms to the ASTM Standard Practice for Environmental Site Assessments: Phase I Environmental Site Assessment Process, E 1527, (ii) was conducted no more than six months prior to the date such report is required to be delivered hereunder, by one or more environmental consulting firms reasonably satisfactory to Administrative Agent, (iii) includes an assessment of asbestos-containing materials at such Facility, (iv) is accompanied by (a) an estimate of the reasonable worst-case cost of investigating and remediating any Hazardous Materials Activity identified in the Phase I Report as giving rise to an actual or potential material violation of any Environmental Law or as presenting a material risk of giving rise to a material Environmental Claim, and (b) a current compliance audit setting forth an assessment of Holdings’, its Subsidiaries’ and such Facility’s current and past compliance with Environmental Laws and an estimate of the cost of rectifying any non-compliance with current Environmental Laws identified therein and the cost of compliance with reasonably anticipated future Environmental Laws identified therein.

  • Project Management Report means each report prepared in accordance with Section 4.02 of this Agreement;

  • Phase 3 Study means a clinical study of an investigational product in patients that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to obtain Regulatory Approval in any country as described in 21 C.F.R. 312.21(c), or a comparable Clinical Study prescribed by the relevant Regulatory Authority in a country other than the United States. The investigational product can be administered to patients as a single agent or in combination with other investigational or marketed agents [***]

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.